SRC Proximal and Core Promoter Elements Dictate TAF1 Dependence and Transcriptional Repression by Histone Deacetylase Inhibitors
Open Access
- 1 March 2004
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 24 (6) , 2296-2307
- https://doi.org/10.1128/mcb.24.6.2296-2307.2004
Abstract
Histone deacetylase inhibitors (HDIs) induce cell cycle arrest, differentiation, or apoptosis in numerous cancer cell types both in vivo and in vitro. These dramatic effects are the result of a specific reprogramming of gene expression. However, the mechanism by which these agents activate the transcription of some genes, such as p21WAF1, but repress others, such as cyclin D1, is currently unknown. We have been studying the human SRC gene as a model for HDI-mediated transcriptional repression. We found previously that both the tissue-specific and housekeeping SRC promoters were equally repressed by HDIs. Here we show that, despite an overt dissimilarity, both SRC promoters do share similar core promoter elements and transcription is TAF1 dependent. Detailed analysis of the SRC promoters suggested that both core and proximal promoter elements were responsible for HDI-mediated repression. This was confirmed in a series of promoter-swapping experiments with the HDI-inducible, TAF1-independent p21WAF1 promoter. Remarkably, all the SRC-p21WAF1 chimeric promoter constructs were not only repressed by HDIs but also dependent on TAF1. Together these experiments suggest that the overall promoter architecture, rather than discrete response elements, is responsible for HDI-mediated repression, and they implicate core promoter elements in particular as potential mediators of this response.Keywords
This publication has 56 references indexed in Scilit:
- Expression of p21WAF1/Cip1 through Sp1 sites by histone deacetylase inhibitor apicidin requires PI 3-kinase–PKCε signaling pathwayOncogene, 2003
- Transcriptional Response of a Human Colon Adenocarcinoma Cell Line to Sodium ButyrateBiochemical and Biophysical Research Communications, 2001
- An Alternative, Human SRC Promoter and Its Regulation by Hepatic Nuclear Factor-1αJournal of Biological Chemistry, 2000
- DNA binding site selection by RNA polymerase II TAFs: a TAFII250-TAFII150 complex recognizes the InitiatorThe EMBO Journal, 1999
- Butyrate inhibits colon carcinoma cell growth through two distinct pathwaysSurgery, 1998
- What's Up and Down with Histone Deacetylation and Transcription?Cell, 1997
- Direct Inhibition of the Expression of Cyclin D1 Gene by Sodium ButyrateBiochemical and Biophysical Research Communications, 1996
- Promoter-Selective Transcriptional Defect in Cell Cycle Mutant ts13 Rescued by hTAF II 250Science, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Regulation of c‐myc expression by sodium butyrate in the colon carcinoma cell line Caco‐2FEBS Letters, 1993